.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
QuintilesIMS
Cantor Fitzgerald
Fish and Richardson
McKinsey
US Army
Healthtrust
Novartis
McKesson
Harvard Business School

Generated: November 23, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 071279

« Back to Dashboard
NDA 071279 describes METHYLDOPATE HYDROCHLORIDE, which is a drug marketed by Marsam Pharms Llc, Smith And Nephew, Hospira, Abraxis Pharm, Teva Parenteral, Luitpold, and Baxter Hlthcare, and is included in ten NDAs. It is available from one supplier. Additional details are available on the METHYLDOPATE HYDROCHLORIDE profile page.

The generic ingredient in METHYLDOPATE HYDROCHLORIDE is methyldopate hydrochloride. There are three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the methyldopate hydrochloride profile page.

Summary for 071279

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 071279

Mechanism of ActionAdrenergic alpha2-Agonists

Suppliers and Packaging for NDA: 071279

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
METHYLDOPATE HYDROCHLORIDE
methyldopate hydrochloride
INJECTABLE;INJECTION 071279 ANDA American Regent, Inc. 0517-8905 0517-8905-10 10 VIAL, SINGLE-DOSE in 1 BOX (0517-8905-10) > 5 mL in 1 VIAL, SINGLE-DOSE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength50MG/ML
Approval Date:Oct 2, 1987TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Cipla
McKinsey
Mallinckrodt
Citi
Medtronic
US Army
US Department of Justice
Novartis
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot